20 May 2013
Keywords: astex, gets, approval, phi, trial, at7519, cambridge
Article | 30 May 2005
Cambridge, UK-based Astex, the fragment-based drug discovery and development company, says that the UK Medicines and Healthcare products
Regulatory Agency ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 May 2005
17 May 2013
© 2013 thepharmaletter.com